Albumin as a prognostic marker for ulcerative colitis

Area of Science:

• Gastroenterology
• Internal Medicine
• Clinical Research

Background:

• Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
• Predicting the clinical course of UC at diagnosis is crucial for patient management.
• Albumin levels may reflect disease severity and nutritional status.

Purpose of the Study:

• To evaluate if albumin levels at the time of ulcerative colitis diagnosis can predict the disease's clinical course.
• To identify hypoalbuminemia as a potential prognostic marker in newly diagnosed UC patients.

Main Methods:

• A nationwide cohort of newly diagnosed UC patients in the Veterans Affairs health care system was analyzed.
• Patients were categorized into hypoalbuminemia (≤ 3.5 gm/dL) or normal albumin (> 3.5 gm/dL) groups at diagnosis.
• Follow-up assessed the use of corticosteroids, thiopurines, anti-TNF medications, and colectomy.

Main Results:

• Of 710 included patients, 174 had hypoalbuminemia at diagnosis.
• Hypoalbuminemic patients showed a higher likelihood of requiring ≥ 2 courses of corticosteroids (aHR=1.7) and thiopurine or anti-TNF therapy (aHR=1.72).
• A trend towards higher colectomy rates was observed in hypoalbuminemic patients, though not statistically significant (aHR=1.7).

Conclusions:

• Hypoalbuminemia at the time of ulcerative colitis diagnosis is a significant prognostic marker.
• It predicts a more aggressive clinical course requiring intensified medical therapy.
• Albumin levels at diagnosis can aid in stratifying UC patients' risk.